Biomarkers Unveil Insights into Pathology of Transitional Epithelial States in Pulmonary Fibrosis
Am J Respir Crit Care Med
.
2024 Sep 1;210(5):687-690.
doi: 10.1164/rccm.202310-1839LE.
Authors
Christopher Ting
1
,
Kristine Konopka
2
,
Rachel E Benedeck
3
,
David W H Riches
4
5
6
,
Elizabeth F Redente
4
5
,
Justin M Oldham
1
,
Rachel L Zemans
1
3
Affiliations
1
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine.
2
Department of Pathology, and.
3
Program in Cellular and Molecular Biology, School of Medicine, University of Michigan, Ann Arbor, Michigan.
4
Program in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, Colorado.
5
Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado; and.
6
Department of Research, Veterans Affairs Eastern Colorado Health Care System, Denver, Colorado.
PMID:
38889340
PMCID:
PMC11389567
(available on
2025-09-01
)
DOI:
10.1164/rccm.202310-1839LE
No abstract available
Publication types
Letter
MeSH terms
Biomarkers*
Humans
Male
Pulmonary Fibrosis* / physiopathology
Substances
Biomarkers
Grants and funding
F32 HL172379/HL/NHLBI NIH HHS/United States
T32 GM145470/GM/NIGMS NIH HHS/United States